---
title: "Multiaspect layered double hydroxide nanohybrid counteracts pathophysiological cascade for ischemic stroke intervention."
description: "Ischemic stroke (IS) therapy remains challenging due to dynamic ischemia-reperfusion pathology. Here, we propose a hybrid nanosheet platform (S-E@LDH) consisting of a layered double hydroxide (LDH) matrix MgAlRu with broad-spectrum enzyme mimetic act..."
date: "2026-02-20"
category: "ia-radiologia"
pubmedId: "41724243"
author: "Yize Dong, Yihong Su, Guangjie Sun et al."
tags: ["Ischemic stroke", "Layered double hydroxide", "Multi-targeted intervention", "Nanomedicine", "Oxidative stress"]
---

## Resumen

Ischemic stroke (IS) therapy remains challenging due to dynamic ischemia-reperfusion pathology. Here, we propose a hybrid nanosheet platform (S-E@LDH) consisting of a layered double hydroxide (LDH) matrix MgAlRu with broad-spectrum enzyme mimetic activity, with the addition of the calcium chelator ethylene glycol tetraacetic acid (EGTA) and the anti-inflammatory agent salvianic acid A (SAA), which rationally integrates the "calcium dysregulation-oxidative stress-inflammation" triple synergistic regulation mode. In the acute phase, cellular damage is reduced by effectively chelating Ca2+, scavenging reactive oxygen/nitrogen and disrupting the Ca2+-ROS amplification loop. Importantly, SAA stabilized in the LDH matrix undergoes spatiotemporally controlled release relying on the acidic pH of the post-ischemic environment, and targeted, precise administration reprograms microglia to an M2 phenotype, helping to restore brain homeostasis. In a mouse model of transient ischemia, S-E@LDH reduces neuronal damage, neuroinflammation and cerebral edema, improving motor function. This multi-targeted nanosheet offers spatiotemporally controlled therapy for IS, addressing its complex pathogenesis.

## Información del artículo

- **Revista:** Journal of controlled release : official journal of the Controlled Release Society
- **Fecha de publicación:** 2026-02-20
- **Autores:** Yize Dong, Yihong Su, Guangjie Sun, Jiali Deng, Xiaowen Wang
- **DOI:** [10.1016/j.jconrel.2026.114737](https://doi.org/10.1016/j.jconrel.2026.114737)
- **PubMed ID:** [41724243](https://pubmed.ncbi.nlm.nih.gov/41724243/)

## Referencias

Este artículo fue obtenido automáticamente desde [PubMed](https://pubmed.ncbi.nlm.nih.gov/41724243/), la base de datos de literatura biomédica del National Center for Biotechnology Information (NCBI).
